aerosolized agent
Jump to navigation
Jump to search
Indications
- aersolized bronchodilators are used for treatment of
- bronchitis
- chronic bronchitis
- COPD exacerbation
- less useful for pulmonary emphysema
- asthma
- cough due to bronchospasm
- bronchitis
Dosage
administered by
- metered-dose inhaler
- nebulizer
- dry powder inhaler (Turbuhaler, Advair Diskus)
More general terms
More specific terms
- aerosolized morphine (nebulized morphine)
- CFTR gene-liposome complex
- inhaled anticholinergic agent
- inhaled beta-2 adrenergic receptor agonist
- inhaled glucocorticoid
- inhaled levodopa (CVT-301)
- insulin inhalation (Exubera, Afrezza)
Additional terms
References
- ↑ Dolovich MB, Ahrens RC, Hess DR, Anderson P, Dhand R, Rau JL, Smaldone GC, Guyatt G. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest. 2005 Jan;127(1):335-71. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/15654001 <Internet> http://www.chestjournal.org/cgi/content/full/127/1/335 (corresponding NGC guideline withdrawn Nov 2015)
- ↑ Prescriber's Letter 12(3): 2005 Common Inhaled Asthma Medications - Dose Comparison and Tips for Use Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=210303&pb=PRL (subscription needed) http://www.prescribersletter.com